Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on July 11, 2005

Circulation. 2005
Published online before print July 11, 2005, doi: 10.1161/CIRCULATIONAHA.104.512834
A more recent version of this article appeared on July 19, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
112/3/416    most recent
CIRCULATIONAHA.104.512834v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Pulmonary Embolism
Related Collections
Right arrow Deep vein thrombosis
Right arrow Other Treatment

Submitted on October 6, 2004
Revised on February 18, 2005
Accepted on March 3, 2005

Eight-Year Follow-Up of Patients With Permanent Vena Cava Filters in the Prevention of Pulmonary Embolism. The PREPIC (Prévention du Risque d’Embolie Pulmonaire par Interruption Cave) Randomized Study

The PREPIC Study Group

From the Thrombosis Research Group, Clinical Pharmacology Department, University Hospital, Saint-Etienne, France.

Background--In a randomized trial in patients with proximal deep-vein thrombosis, permanent vena cava filters reduced the incidence of pulmonary embolism but increased that of deep-vein thrombosis at 2 years. An 8-year follow-up was performed to assess their very long-term effect.

Methods and Results--Four hundred patients with proximal deep-vein thrombosis with or without pulmonary embolism were randomized either to receive or not receive a filter in addition to standard anticoagulant treatment for at least 3 months. Data on vital status, venous thromboembolism, and postthrombotic syndrome were obtained once a year for up to 8 years. All documented events were reviewed blindly by an independent committee. Outcome data were available in 396 patients (99%). Symptomatic pulmonary embolism occurred in 9 patients in the filter group (cumulative rate 6.2%) and 24 patients (15.1%) in the no-filter group (P=0.008). Deep-vein thrombosis occurred in 57 patients (35.7%) in the filter group and 41 (27.5%) in the no-filter group (P=0.042). Postthrombotic syndrome was observed in 109 (70.3%) and 107 (69.7%) patients in the filter and no-filter groups, respectively. At 8 years, 201 (50.3%) patients had died (103 and 98 patients in the filter and no-filter groups, respectively).

Conclusions--At 8 years, vena cava filters reduced the risk of pulmonary embolism but increased that of deep-vein thrombosis and had no effect on survival. Although their use may be beneficial in patients at high risk of pulmonary embolism, systematic use in the general population with venous thromboembolism is not recommended.


Key words: vena cava filters • prevention • thrombosis • trials • pulmonary embolism




This article has been cited by other articles:


Home page
ChestHome page
C. Kearon, S. R. Kahn, G. Agnelli, S. Goldhaber, G. E. Raskob, and A. J. Comerota
Antithrombotic Therapy for Venous Thromboembolic Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 454S - 545S.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Laporte, P. Mismetti, H. Decousus, F. Uresandi, R. Otero, J. L. Lobo, M. Monreal, and the RIETE Investigators
Clinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous Thromboembolism: Findings From the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry
Circulation, April 1, 2008; 117(13): 1711 - 1716.
[Abstract] [Full Text] [PDF]


Home page
INT J LOW EXTREM WOUNDSHome page
M. P. Janjigian and B. E. Muhs
Current Treatment of Acute Lower Extremity Deep Venous Thrombosis
International Journal of Lower Extremity Wounds, March 1, 2008; 7(1): 15 - 20.
[Abstract] [PDF]


Home page
cfpHome page
J. Chung and R. J.T. Owen
Using inferior vena cava filters to prevent pulmonary embolism
Can Fam Physician, January 1, 2008; 54(1): 49 - 55.
[Abstract] [Full Text] [PDF]


Home page
Am Soc Clin Oncol Ed BookHome page
A. Falanga, A. Y. Y. Lee, M. B. Streiff, and G. H. Lyman
Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer
ASCO Educational Book, January 1, 2008; 2008(1): 258 - 268.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
G. H. Lyman, A. A. Khorana, A. Falanga, D. Clarke-Pearson, C. Flowers, M. Jahanzeb, A. Kakkar, N. M. Kuderer, M. N. Levine, H. Liebman, et al.
American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer
J. Clin. Oncol., December 1, 2007; 25(34): 5490 - 5505.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
The van Gogh Investigators
Extended Prophylaxis of Venous Thromboembolism with Idraparinux
N. Engl. J. Med., September 13, 2007; 357(11): 1105 - 1112.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. A. Yegen, D. J. Lederer, R. G. Barr, J. S. Wilt, Y. Fang, E. Bagiella, F. D'Ovidio, J. M. Okun, J. R. Sonett, S. M. Arcasoy, et al.
Risk Factors for Venous Thromboembolism After Lung Transplantation
Chest, August 1, 2007; 132(2): 547 - 553.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. J. Carlbom and B. L. Davidson
Pulmonary Embolism in the Critically Ill
Chest, July 1, 2007; 132(1): 313 - 324.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. Hoppe, J. A. Kaufman, R. E. Barton, B. D. Petersen, P. C. Lakin, T. G. DeLoughery, Z. Irani, K. Yavuz, and F. S. Keller
Safety of Inferior Vena Cava Filter Retrieval in Anticoagulated Patients
Chest, July 1, 2007; 132(1): 31 - 36.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
C. A. Binkert, M. C. Morash, and J. D. Gates
Venographic Findings at Retrieval of Inferior Vena Cava Filters
Am. J. Roentgenol., April 1, 2007; 188(4): 1039 - 1043.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. B. Segal, M. B. Streiff, L. V. Hofmann, K. Thornton, and E. B. Bass
Management of Venous Thromboembolism: A Systematic Review for a Practice Guideline
Ann Intern Med, February 6, 2007; 146(3): 211 - 222.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
A. Falanga and F. R. Rickles
Management of Thrombohemorrhagic Syndromes (THS) in Hematologic Malignancies
Hematology, January 1, 2007; 2007(1): 165 - 171.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
D. Scarvelis and P. S. Wells
Diagnosis and treatment of deep-vein thrombosis.
Can. Med. Assoc. J., October 24, 2006; 175(9): 1087 - 1092.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Med.Home page
Additional articles abstracted in ACP Journal Club
Evid. Based Med., February 1, 2006; 11(1): 30 - 30.
[Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
Do Vena Cava Filters Prevent PE?
Journal Watch Cardiology, September 2, 2005; 2005(902): 5 - 5.
[Full Text]


Home page
SURG INNOVHome page
R. F. Sing, F. B. Rogers, Y. W. Novitsky, and B. T. Heniford
Optional Vena Cava Filters for Patients with High Thromboembolic Risk: Questions to be Answered
Surgical Innovation, September 1, 2005; 12(3): 195 - 202.
[Abstract] [PDF]


Home page
CirculationHome page
J. Ansell
Vena Cava Filters: Do We Know All That We Need to Know?
Circulation, July 19, 2005; 112(3): 298 - 299.
[Full Text] [PDF]